Free Trial

Oxford Nanopore Technologies (LON:ONT) Trading Down 10.2% - Time to Sell?

Oxford Nanopore Technologies logo with Medical background

Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) shares traded down 10.2% on Monday . The company traded as low as GBX 127 ($1.59) and last traded at GBX 128.50 ($1.61). 3,354,197 shares were traded during mid-day trading, an increase of 54% from the average session volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.79).

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Berenberg Bank reiterated a "buy" rating and set a GBX 282 ($3.54) target price on shares of Oxford Nanopore Technologies in a research report on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 190 ($2.38) price objective on shares of Oxford Nanopore Technologies in a research report on Wednesday, September 4th. Finally, JPMorgan Chase & Co. reiterated an "overweight" rating on shares of Oxford Nanopore Technologies in a research report on Friday, December 6th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of GBX 235.50 ($2.95).

Check Out Our Latest Stock Analysis on ONT

Oxford Nanopore Technologies Price Performance

The company has a debt-to-equity ratio of 8.07, a quick ratio of 6.01 and a current ratio of 4.45. The stock's 50-day moving average is GBX 142.50 and its two-hundred day moving average is GBX 129.78. The stock has a market cap of £1.21 billion, a PE ratio of -642.50 and a beta of 0.80.

Insiders Place Their Bets

In other news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the company's stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of GBX 142 ($1.78), for a total transaction of £2,830,870.82 ($3,548,791.30). Insiders have acquired 310 shares of company stock worth $45,010 over the last three months. Company insiders own 32.62% of the company's stock.

About Oxford Nanopore Technologies

(Get Free Report)

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.

Featured Stories

Should You Invest $1,000 in Oxford Nanopore Technologies Right Now?

Before you consider Oxford Nanopore Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Nanopore Technologies wasn't on the list.

While Oxford Nanopore Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines